ALDX Annual Total Expenses
$42.79 M
-$19.89 M-31.73%
31 December 2023
Summary:
As of January 23, 2025, ALDX annual total expenses is $42.79 million, with the most recent change of -$19.89 million (-31.73%) on December 31, 2023. During the last 3 years, it has risen by +$8.13 million (+23.44%). ALDX annual total expenses is now -31.73% below its all-time high of $62.68 million, reached on December 31, 2022.ALDX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALDX Quarterly Total Expenses
$16.14 M
-$1.87 M-10.39%
30 September 2024
Summary:
As of January 23, 2025, ALDX quarterly total expenses is $16.14 million, with the most recent change of -$1.87 million (-10.39%) on September 30, 2024. Over the past year, it has increased by +$6.59 million (+68.97%). ALDX quarterly total expenses is now -15.35% below its all-time high of $19.06 million, reached on September 30, 2019.ALDX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALDX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.7% | +69.0% |
| 3 y3 years | +23.4% | +4.5% |
| 5 y5 years | +7.8% | -15.3% |
ALDX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.7% | at low | -10.4% | +164.7% |
| 5 y | 5-year | -31.7% | +23.4% | -10.4% | +164.7% |
| alltime | all time | -31.7% | +3740.8% | -15.3% | >+9999.0% |
Aldeyra Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.14 M(-10.4%) |
| June 2024 | - | $18.01 M(+91.7%) |
| Mar 2024 | - | $9.39 M(+54.1%) |
| Dec 2023 | $42.79 M(-31.7%) | $6.10 M(-36.2%) |
| Sept 2023 | - | $9.55 M(-7.7%) |
| June 2023 | - | $10.34 M(-38.4%) |
| Mar 2023 | - | $16.80 M(+22.7%) |
| Dec 2022 | $62.68 M(+11.5%) | $13.70 M(-7.4%) |
| Sept 2022 | - | $14.78 M(-16.5%) |
| June 2022 | - | $17.71 M(+7.5%) |
| Mar 2022 | - | $16.48 M(+7.0%) |
| Dec 2021 | $56.22 M(+62.2%) | $15.40 M(-0.2%) |
| Sept 2021 | - | $15.44 M(+6.2%) |
| June 2021 | - | $14.54 M(+34.3%) |
| Mar 2021 | - | $10.83 M(+13.6%) |
| Dec 2020 | $34.67 M(-38.6%) | $9.53 M(+13.6%) |
| Sept 2020 | - | $8.39 M(+18.1%) |
| June 2020 | - | $7.11 M(-26.3%) |
| Mar 2020 | - | $9.64 M(-24.9%) |
| Dec 2019 | $56.51 M(+42.3%) | $12.83 M(-32.7%) |
| Sept 2019 | - | $19.06 M(+38.3%) |
| June 2019 | - | $13.78 M(+27.2%) |
| Mar 2019 | - | $10.83 M(-2.4%) |
| Dec 2018 | $39.70 M | $11.10 M(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $10.95 M(+19.4%) |
| June 2018 | - | $9.17 M(+7.9%) |
| Mar 2018 | - | $8.49 M(+20.5%) |
| Dec 2017 | $22.49 M(+20.3%) | $7.05 M(+40.5%) |
| Sept 2017 | - | $5.02 M(-5.9%) |
| June 2017 | - | $5.33 M(+4.6%) |
| Mar 2017 | - | $5.10 M(+9.5%) |
| Dec 2016 | $18.70 M(+55.9%) | $4.65 M(-2.6%) |
| Sept 2016 | - | $4.78 M(+11.2%) |
| June 2016 | - | $4.30 M(-13.5%) |
| Mar 2016 | - | $4.97 M(+14.5%) |
| Dec 2015 | $11.99 M(+64.9%) | $4.34 M(+30.0%) |
| Sept 2015 | - | $3.34 M(+51.4%) |
| June 2015 | - | $2.20 M(+4.5%) |
| Mar 2015 | - | $2.11 M(-12.5%) |
| Dec 2014 | $7.27 M(+97.8%) | $2.41 M(+22.5%) |
| Sept 2014 | - | $1.97 M(+19.5%) |
| June 2014 | - | $1.65 M(+32.3%) |
| Mar 2014 | - | $1.24 M(+1.0%) |
| Dec 2013 | $3.68 M(+230.0%) | $1.23 M(+5.7%) |
| Sept 2013 | - | $1.17 M(+18.3%) |
| June 2013 | - | $985.70 K(+238.1%) |
| Mar 2013 | - | $291.50 K(+150.4%) |
| Dec 2012 | $1.11 M(-47.2%) | $116.40 K |
| Dec 2011 | $2.11 M | - |
FAQ
- What is Aldeyra Therapeutics annual total expenses?
- What is the all time high annual total expenses for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual total expenses year-on-year change?
- What is Aldeyra Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly total expenses year-on-year change?
What is Aldeyra Therapeutics annual total expenses?
The current annual total expenses of ALDX is $42.79 M
What is the all time high annual total expenses for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual total expenses is $62.68 M
What is Aldeyra Therapeutics annual total expenses year-on-year change?
Over the past year, ALDX annual total expenses has changed by -$19.89 M (-31.73%)
What is Aldeyra Therapeutics quarterly total expenses?
The current quarterly total expenses of ALDX is $16.14 M
What is the all time high quarterly total expenses for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly total expenses is $19.06 M
What is Aldeyra Therapeutics quarterly total expenses year-on-year change?
Over the past year, ALDX quarterly total expenses has changed by +$6.59 M (+68.97%)